In IBC, molecular characteristics that combine to cause increased proliferation and angiogenesis may be causative factors rather than the traditional ideas of high incidence of ER- and HER2 status which serves to oversimplify the IBC profile. The gene discussed is ESR1; the disease is inflammatory breast carcinoma.